Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The approval of a new drug that can slow the progress of Alzheimer’s disease is being hailed as a historic moment in the ...
Stocktwits on MSN
Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up
Spirit of the Coast Analytics said Anavex’s Alzheimer’s drug Blarcamesine is likely to gain conditional marketing ...
Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...
Having lower cholesterol levels may help protect against dementia, according to a large-scale international study led by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results